Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008

y related

to the potential settlement of the investigations by the U.S.

Attorney's Office.

(4) To exclude the pre-tax gain related to the sale of certain


(5) To exclude an estimate of accrued interest related to the agreement

in principle reached with the U.S. Attorney's Office in Philadelphia.

(6) To exclude costs related to the CIMA Labs restructuring announced in

January 2008.

(7) To reflect the tax effect of pre-tax adjustments at the applicable

tax rates and certain other tax adjustments primarily related to

changes in valuation allowances and other changes in tax assets and



Reconciliation of GAAP Net Income to Adjusted Net Income


Six Months Ended

June 30,

2008 2007

GAAP NET INCOME $ 98,919 $ 70,877

Cost of sales adjustments 56,780(1) 41,981(1)

Research and development adjustments 7,754(2) 26,500(2)

Selling, general and administrative

adjustments 2,955(3) -

Settlement reserve - 56,000(4)

Gain on sale of investment - (5,791)(5)

Interest expense adjustment 7,500(6) -

Restructuring adjustment 5,476(7) -

In-process research and development

adjustments 10,000(8) -

Income tax adjustment (29,329)(

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
(Date:10/8/2015)... 2015 .   ... Goldman Small Cap Research, a stock market ... microcap sectors, announced today that it has published ... Inc. (OTCQB - PMCB), a publicly traded, clinical ... treatments for cancer and diabetes. To view the ...
(Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... CA (PRWEB) , ... October 08, 2015 , ... ... mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results in ... viscous and sticky mucus accumulates in the lungs. This mucus is very difficult ...
(Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. ... and nutritional ingredients that creates science-based solutions for ... nutrition, and pharmaceutical products, today announced that the ... CEO and Founder, is now available for on-demand ... -->   --> ...
Breaking Biology Technology:
... , ... integral to the SPEX FLUOROMAX -P or as an accessory ... information on various systems of chemical and biochemical interest, by revealing data ... <P,>This Application Note describes an example, using the SPEX ...
... , ... DataMax is the software used to display data from all SPEX ... a contour map. A contour map displays multifiles or 3-D data, and ... meteorological plot of barometric pressures. X values are plotted on the horizontal ...
... Introduction , ... 1 O 2 , is of considerable interest in environmental applications, ... been directed towards understanding the biological effects of 1 O 2 ... a dye, oxygen, and light. <P,>An understanding of the mechanisms that produce ...
Cached Biology Technology:
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)... YORK , Sept. 28, 2015 /PRNewswire/ ... announced today that its expedited traveler service ... innovative platform transforms travel, bringing a frictionless ... its members. "CLEAR offers our ... enhances customer service," said Jim Smith ...
(Date:9/28/2015)... -- According to a new market research ... & Others), Application (Access Control & Others), Industry (Travel ... Global - Forecast to 2020", published by MarketsandMarkets, the Iris ... by 2020, at a CAGR of 23.40% between 2015 ... T ables and 66 Figures spread ...
Breaking Biology News(10 mins):
... that the dawn of agriculture may have come with ... some 11,400 years ago, roughly a thousand years before ... in the region. The discovery dates domesticated figs to ... making the fruit trees the oldest known domesticated crop. ...
... combining the four bacterial surface proteins that generate ... the University of Chicago have created a vaccine ... drug-resistant strains of Staphylococcus aureus, the most common ... source of community-associated illness. , The vaccine ...
... June 15th issue of G&D, Dr. Marie-Louise Hammarskjold (UVA) ... the Wilms' Tumor 1 tumor suppressor. The Wilms' Tumor ... pathological human development, with known roles in kidney and ... , Dr. Hammarskjold and colleagues reveal that WT1 works ...
Cached Biology News:
... a silica based spin filter membrane to isolate ... DNA band is cut from an agarose gel ... The gel slice is melted irreversibly in a ... bound to the silica spin filter membrane and ...
... incorporation of Br-dUTP results in a stronger ... a fluorescein-labeled anti-BrdU antibody. Propidium iodide/RNase ... to counterstain the total DNA. Features and ... improved detection than found by using biotin- ...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Biology Products: